Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization […]
New biologic for adults with moderate to severe plaque psoriasis may be available this summer. Plaque psoriasis is the most common form of the autoimmune disease April 11, 2018 For the millions of Americans who have plaque psoriasis, the most common type of psoriasis, a new treatment option is coming to market. The Food and […]
Less than a month after claiming FDA approval for its new HIV therapy Biktarvy, Gilead Sciences has reported new data claiming patients can safely switch to its drug from rival ViiV Healthcare’s Triumeq. The results of Study 1844 showed that patients who transferred to treatment with Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) from Triumeq (abacavir/dolutegravir/lamivudine) were able to […]
First HIV treatment approved with a new mechanism of action in more than 10 years Infused every two weeks, only antiretroviral treatment (ART) that does not require daily dosing Trogarzo™ has no drug-drug interactions and no cross-resistance with other ARTs Theratechnologies Announces FDA Approval of Breakthrough Therapy, Trogarzo™ (ibalizumab-uiyk) Injection, the First HIV-1 Inhibitor and […]
Scientific evidence has shown links among HIV, human papillomavirus (HPV), and cervical cancer.1 Subsequently, UNAIDS and the World Health Organization have called for leveraging the synergies between these conditions to improve patient outcomes by developing integrated approaches that address HIV, child and adolescent health, sexual and reproductive health and rights, gender equality, and cancer and primary […]